Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TALAVE: A Pilot Trial of Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

NCT03964532 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT03964532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03964532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TALAVE: A Pilot Trial of Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
Lead sponsor
Georgetown University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
April 19, 2019
Completion date
April 30, 2027
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer